SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 325 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $5,000 | -88.9% | 70 | -87.7% | 0.00% | -87.5% |
Q1 2022 | $45,000 | -11.8% | 570 | 0.0% | 0.01% | 0.0% |
Q4 2021 | $51,000 | -48.5% | 570 | -46.7% | 0.01% | -55.6% |
Q3 2021 | $99,000 | +19.3% | 1,070 | 0.0% | 0.02% | +20.0% |
Q2 2021 | $83,000 | +3.8% | 1,070 | 0.0% | 0.02% | -16.7% |
Q1 2021 | $80,000 | -18.4% | 1,070 | +85.8% | 0.02% | -28.0% |
Q4 2020 | $98,000 | +60.7% | 576 | +32.1% | 0.02% | +25.0% |
Q3 2020 | $61,000 | +60.5% | 436 | +84.7% | 0.02% | +33.3% |
Q2 2020 | $38,000 | +81.0% | 236 | +11.8% | 0.02% | +50.0% |
Q1 2020 | $21,000 | +50.0% | 211 | +99.1% | 0.01% | +100.0% |
Q4 2019 | $14,000 | +75.0% | 106 | 0.0% | 0.01% | +25.0% |
Q3 2019 | $8,000 | -50.0% | 106 | 0.0% | 0.00% | -42.9% |
Q2 2019 | $16,000 | +1500.0% | 106 | +1666.7% | 0.01% | +600.0% |
Q1 2019 | $1,000 | – | 6 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |